Literature DB >> 18418799

BCG scar and tuberculin reactivity in children and adults.

Harald Fjällbrant1, Malin Ridell, Lars Olof Larsson.   

Abstract

Bacille Calmette-Guérin (BCG) vaccination generally leads to scar formation and tuberculin skin test (TST) reactivity. This study aimed at analysing these 2 parameters and their correlation in a setting with a low prevalence of tuberculosis. Retrospectively, we analysed 314 children and 390 adults living in Sweden and known from records or individual recall to have undergone BCG vaccination. A BCG scar was present in 161 (51%) of the children and in 340 (87%) of the adults. Among children with a scar, 94 (58%) were TST-positive (>or=6 mm) compared to 23 (15%) of 154 children lacking a visible scar. Among adults with a scar, 258 (76%) were TST- positive compared to 23 (46%) of 50 with no scar. Out of 152 non-vaccinated adults, 142 (94.4%) were TST-negative. When 175 TST-negative health care students were BCG-vaccinated in a prospective part of the study, 174 (99%) were found to develop a scar. In essence, the study showed a positive correlation between scar presence and TST reactivity. Furthermore, BCG vaccination of adults in the present setting resulted in consistent scar formation, while scar prevalence in previously vaccinated children was low.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418799     DOI: 10.1080/00365540701732905

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Is there interference in the interpretation of the tuberculin skin test in children with intestinal parasitic infestation?

Authors:  Roi Piñeiro-Pérez; Milagros García-Hortelano; María José Mellado; Marta García-Ascaso; Antonio Medina-Claros; Nuria Fernández; Mercedes Subirats; María José Cilleruelo
Journal:  Pathog Glob Health       Date:  2012-07       Impact factor: 2.894

2.  Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results?

Authors:  Roi Piñeiro; María José Mellado; María José Cilleruelo; Marta García-Ascaso; Antonio Medina-Claros; Milagros García-Hortelano
Journal:  Eur J Pediatr       Date:  2012-07-01       Impact factor: 3.183

3.  Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda.

Authors:  Daniel Mumpe-Mwanja; Suzanne Verver; Adoke Yeka; Alfred Etwom; James Waako; Willy Ssengooba; Joseph Kb Matovu; Rhoda K Wanyenze; Phillipa Musoke; Harriet Mayanja-Kizza
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

4.  Effect of nutritional status on Tuberculin skin testing.

Authors:  Roi Piñeiro; María José Cilleruelo; Milagros García-Hortelano; Marta García-Ascaso; Antonio Medina-Claros; María José Mellado
Journal:  Indian J Pediatr       Date:  2012-05-13       Impact factor: 1.967

Review 5.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

6.  Tuberculosis screening among health sciences students in Saudi Arabia in 2010.

Authors:  Manal A Murad; Samia S Abdulmageed
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

7.  Natural unblinding of BCG vaccination trials.

Authors:  Reka Szigeti; Richard Kellermayer
Journal:  Vaccine       Date:  2021-03-18       Impact factor: 3.641

8.  Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).

Authors:  Margret Johansson Gudjónsdóttir; Karsten Kötz; Ruth Stangebye Nielsen; Philip Wilmar; Sofia Olausson; Daniel Wallmyr; Birger Trollfors
Journal:  BMC Infect Dis       Date:  2016-10-06       Impact factor: 3.090

9.  Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth.

Authors:  Sudha Bhavanam; Gina R Rayat; Monika Keelan; Dennis Kunimoto; Steven J Drews
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

10.  BCG epidemiology supports its protection against COVID-19? A word of caution.

Authors:  Reka Szigeti; Domos Kellermayer; Giedrius Trakimas; Richard Kellermayer
Journal:  PLoS One       Date:  2020-10-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.